SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,779,721 | +7.5% | 863,932 | +145.5% | 0.00% | 0.0% |
| Q2 2023 | $16,546,855 | +5.8% | 351,911 | -5.6% | 0.00% | 0.0% |
| Q1 2023 | $15,636,476 | -18.6% | 372,652 | -26.0% | 0.00% | 0.0% |
| Q4 2022 | $19,208,640 | +44.0% | 503,635 | +47.8% | 0.00% | 0.0% |
| Q3 2022 | $13,342,000 | -27.9% | 340,715 | -40.6% | 0.00% | 0.0% |
| Q2 2022 | $18,517,000 | -1.0% | 573,300 | +1.4% | 0.00% | -33.3% |
| Q1 2022 | $18,705,000 | +52.4% | 565,122 | +95.9% | 0.00% | +50.0% |
| Q4 2021 | $12,274,000 | -17.3% | 288,528 | -13.8% | 0.00% | 0.0% |
| Q3 2021 | $14,837,000 | -54.8% | 334,840 | -42.0% | 0.00% | -50.0% |
| Q2 2021 | $32,820,000 | +77.4% | 577,716 | +133.7% | 0.00% | +33.3% |
| Q1 2021 | $18,500,000 | +34.2% | 247,175 | +55.1% | 0.00% | +50.0% |
| Q4 2020 | $13,785,000 | -15.1% | 159,349 | -40.0% | 0.00% | -33.3% |
| Q3 2020 | $16,241,000 | +156.0% | 265,729 | +74.1% | 0.00% | +200.0% |
| Q2 2020 | $6,345,000 | -77.7% | 152,620 | -84.6% | 0.00% | -87.5% |
| Q1 2020 | $28,516,000 | +368.6% | 992,855 | +1077.6% | 0.01% | +700.0% |
| Q4 2019 | $6,085,000 | -31.6% | 84,309 | +33.0% | 0.00% | -50.0% |
| Q3 2019 | $8,894,000 | -48.8% | 63,395 | -33.2% | 0.00% | -60.0% |
| Q2 2019 | $17,370,000 | +33.6% | 94,877 | +16.0% | 0.01% | +25.0% |
| Q1 2019 | $13,006,000 | +56.9% | 81,773 | -5.5% | 0.00% | +100.0% |
| Q4 2018 | $8,291,000 | -38.3% | 86,562 | -9.0% | 0.00% | -33.3% |
| Q3 2018 | $13,443,000 | -28.9% | 95,165 | -21.3% | 0.00% | -40.0% |
| Q2 2018 | $18,920,000 | -26.2% | 120,869 | -24.0% | 0.01% | -28.6% |
| Q1 2018 | $25,631,000 | -19.4% | 159,136 | -17.6% | 0.01% | -22.2% |
| Q4 2017 | $31,815,000 | +787.2% | 193,155 | +235.6% | 0.01% | +800.0% |
| Q3 2017 | $3,586,000 | -10.6% | 57,563 | +14.3% | 0.00% | 0.0% |
| Q2 2017 | $4,012,000 | -42.8% | 50,373 | -48.9% | 0.00% | 0.0% |
| Q1 2017 | $7,012,000 | -29.6% | 98,652 | -49.5% | 0.00% | -50.0% |
| Q4 2016 | $9,966,000 | +903.6% | 195,186 | +804.6% | 0.00% | – |
| Q3 2016 | $993,000 | -54.1% | 21,577 | -69.9% | 0.00% | -100.0% |
| Q2 2016 | $2,163,000 | +611.5% | 71,788 | +655.0% | 0.00% | – |
| Q1 2016 | $304,000 | -30.9% | 9,508 | +25.9% | 0.00% | – |
| Q4 2015 | $440,000 | +23.2% | 7,555 | -10.5% | 0.00% | – |
| Q3 2015 | $357,000 | -73.9% | 8,439 | -55.0% | 0.00% | – |
| Q2 2015 | $1,368,000 | +313.3% | 18,740 | +183.8% | 0.00% | – |
| Q1 2015 | $331,000 | +359.7% | 6,603 | +236.7% | 0.00% | – |
| Q4 2014 | $72,000 | +24.1% | 1,961 | +6.3% | 0.00% | – |
| Q3 2014 | $58,000 | – | 1,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |